An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease
Trial end date:
SummaryThe objective of this open-label extension is to assess the safety and tolerability of long-term treatment of the Rotigotine patch in subjects with advanced-stage idiopathic Parkinson's Disease.
Accepts Healthy Volunteers?No
- Subjects who have completed six months of maintenance treatment in the SP650
- Subjects who had an ongoing serious adverse event from the SP650 double-blind trial
that was assessed as related to study medication